Cadherim-6

제품 문의

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Nanrilkefusp alfaSO-C101; RLI-15; CYP-0150; SOT-101Phase 2 ClinicalMicrosatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms
상세
MB-107IND-14570; MB-107Phase 2 ClinicalSt Jude Children's Research Hospital, National Institute Of Allergy And Infectious Diseases (Niaid), National Heart, Lung And Blood Institute, National Institute of Health, IslamabadX-Linked Combined Immunodeficiency Diseases; Immunologic Deficiency Syndromes
상세
GI-101SIM-323; SIM323; GI-101Phase 2 ClinicalGI Innovation IncSolid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis
상세
PegenzileukinTHOR-707; SAR-444245Phase 2 ClinicalSynthorx IncColorectal Neoplasms; Neoplasm Metastasis; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Esophageal adenocarcinoma; Oropharyngeal Neoplasms; Intestinal Neoplasms; Multiple Myeloma; Mesothelioma; Lymphoma, Large B-Cell, Diffuse; Skin Neoplasms; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms
상세
REGN-7257REGN-7257Phase 2 ClinicalAnemia, Aplastic
상세
IAP-0971IAP-0971Phase 2 ClinicalSunHo (China) BioPharmaceutical Co LtdSolid tumours; Neoplasms; Urinary Bladder Neoplasms
상세
TransCon IL-2 β/γPhase 2 ClinicalAscendis Pharma A/SOvarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung
상세
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteX-Linked Combined Immunodeficiency Diseases
상세
Simlukafusp alfaFAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FPPhase 1 ClinicalF. Hoffmann-La Roche LtdHead and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma
상세
BJ-001(Boji Biomedical Technology)BJ-001Phase 1 ClinicalBoji Biomedical Technology (Hangzhou) Co LtdSolid tumours; Communicable Diseases; Neoplasm Metastasis
상세
NL-201 (Neoleukin Therapeutics)NL-201Phase 1 ClinicalNeoleukin Therapeutics IncSolid tumours
상세
Recombinant human interleukin 15(Beijing Kawin)Phase 1 ClinicalBeijing Kawin Technology Share-Holding Co LtdSolid tumours
상세
  • 제품 문의
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호